Drug Trial Radar · NCT07832292
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 16, 2026
Primary completion
May 17, 2029
Study completion May 20, 2030
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well JNJ-101556143 works in participants with metastatic androgen pathway modulation-resistant prostate cancer (mAPMR), an advanced form of prostate cancer that has spread and no longer responds to hormone therapy. The study will measure the overall response (tumor shrinkage or disappearance) following treatment with JNJ-101556143.
Conditions
- Prostatic Neoplasms
Interventions
JNJ-101556143Drug
Participants will receive JNJ-101556143 orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR)Time frame: Up to 2 years and 8 months
Locations
14 sites in 4 countries. Site status is shown where the registry gives one.
Advanced Urology Institute
Largo, Florida · Recruiting
Associated Urological Specialists
Chicago Ridge, Illinois · Recruiting
Urology of Indiana
Carmel, Indiana · Recruiting
Southern Urology LLC
Lafayette, Louisiana · Recruiting
Greater Boston Urology
Plymouth, Massachusetts · Recruiting
Associated Medical Professionals
Syracuse, New York · Recruiting
The Conrad Pearson Clinic
Germantown, Tennessee · Recruiting
Icon Ctr Chermside
Chermside, Australia · Recruiting
Epworth Healthcare
East Melbourne, Australia · Recruiting
Icon Cancer Ctr Hobart
Hobart, Australia · Recruiting
Icon Cancer Centre Kurralta Park
Kurralta Park, Australia · Recruiting
Sun Yat Sen University Cancer Center
Guangzhou, China · Recruiting
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China · Recruiting
Kobe University Hospital
Kobe, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.